+499.5%
MRNA vs ENB
+7.5%
+491.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ENB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.9% | -1.4% | -3.7% |
| 7D | +5.5% | -0.2% | +5.7% | +5.0% |
| 30D | +158.7% | -2.2% | +161.0% | +156.7% |
| 3M | +182.1% | -10.5% | +192.6% | +175.2% |
| 6M | +151.8% | -5.1% | +156.9% | +147.9% |
| YTD | +393.6% | +9.0% | +384.6% | +368.0% |
| 1Y | +499.5% | +8.2% | +491.3% | +479.0% |
| All | +499.5% | +7.5% | +491.9% | +479.0% |
Cumulative growth
Daily Returns
Daily percentage return beside ENB.
Daily Out/Under-Performance
Portfolio return minus ENB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ENB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling